Actress-singer Zendaya — one of those one-named divas like Madonna and Cher — will be appearing in TV and print PSA’s to promote QVC’s 23rd Annual “FFANY Shoes on Sale” charitable event, the home shopping network said Tuesday.
During the three-hour broadcast, set for Oct. 20 from 6 p.m. to 9 p.m., more than 170 donated shoe styles from more than 80 brands will be on sale to raise money to fight breast cancer.
All the shoes will be offered at half the manufacturer’s suggested retail price with a minimum of 80 percent of the purchase price benefiting various breast cancer research and education institutions.
“Like most women, I love a great pair of shoes, and I especially love scoring a great deal,” Zendaya said in a canned statement. “Being a part of QVC Presents ‘FFANY Shoes on Sale’ allows me to share my passion for shoes with my fans while also demonstrating how fun it can be to contribute to such a worthwhile cause.”
The event has generated more than $50 million to date for breast cancer research and education institutions.
“Each year, we look forward to collaborating with the Fashion Footwear Association of New York and providing our customers with a unique shopping experience that not only celebrates the joy of discovery but also the joy of giving back by standing as one against a disease that affects many,” QVC’s top honcho, President and CEO Mike George, said in his canned statement.
“It is an honor to have Zendaya’s support this year and we have no doubt that her captivating spirit will endear her to viewers across the country.”
Beneficiaries for the 2016 QVC Presents “FFANY Shoes on Sale” event include: The Abramson Cancer Center of the University of Pennsylvania; The Breast Cancer Research Foundation; The Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center; The Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute; The University of Michigan Comprehensive Cancer Center’s Breast Oncology Program; The University of Pittsburgh Cancer Institute; The Winthrop P. Rockefeller Cancer Institute of the University of Arkansas for Medical Sciences; The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; and The Margie and Robert E. Petersen Breast Cancer Research Program at the John Wayne Cancer Institute at Providence Saint John’s Health Center.